ELVN:NASDAQ
Enliven Therapeutics Inc
40,98 $
arrow_upward
+0,86%(+0,35) 1D
40,98 $
0,00% (0,00)
bedtimeAfter hours
Closed: 9 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ELVN...
Open
41,00 $
High
42,06 $
Low
40,29 $
Mkt. cap
3,00 млрд
Avg. vol.
1,37 млн
Volume
1,00 млн
52-wk high
62,32 $
52-wk low
14,78 $
EPS
-1,67 $
Beta
0,24
Shares outstanding
73,27 млн
No. of employees
67
Open
41,00 $
High
42,06 $
Low
40,29 $
Mkt. cap
3,00 млрд
Avg. vol.
1,37 млн
Volume
1,00 млн
52-wk high
62,32 $
52-wk low
14,78 $
EPS
-1,67 $
Beta
0,24
Shares outstanding
73,27 млн
No. of employees
67
News stories
From web sources and news partners
Yahoo Finance
·
14 сағат бұрын
Why Enliven Therapeutics' (ELVN) ENABLE-2 Trial Design Raises New Questions About Its CML Strategy
Investing.com
·
2 күн бұрын
Guggenheim reiterates Enliven Therapeutics stock rating on FDA alignment
About Enliven Therapeutics Inc
CEO-
Employees67
Founded2016
HeadquartersБоулдер, Колорадо, Америка Құрама Штаттары
SectorPharmaceutical industry
Websiteimaratx.com